Dundas Valley, Australia

Norbert A Kienzle


Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Macquarie Park, AU (2014)
  • Dundas Valley, AU (2013 - 2015)

Company Filing History:


Years Active: 2013-2015

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Norbert A Kienzle: Innovator in Cancer Treatment

Introduction

Norbert A Kienzle is a notable inventor based in Dundas Valley, Australia. He has made significant contributions to the field of cancer treatment, particularly focusing on therapies involving mutated KRAS and BRAF genes. With a total of 3 patents, Kienzle's work is paving the way for innovative approaches to combat cancer.

Latest Patents

Kienzle's latest patents include a method for treating cancer that involves administering an effective amount of an antibody or antigen binding fragment that competes with SC104 for binding to the human colon cancer cell line Colo205. This method specifically targets cancers with mutated KRAS or BRAF genes. Another significant patent involves humanized antibodies that exhibit anti-tumor activity. These humanized antibodies are designed to bind specifically to human colon tumor cells, demonstrating potent immune-mediated cytotoxic activity against these cells both in vitro and in vivo.

Career Highlights

Throughout his career, Kienzle has worked with prominent companies in the pharmaceutical industry, including Teva Pharmaceuticals Australia Pty Ltd and Cephalon Australia Pty Ltd. His experience in these organizations has contributed to his expertise in developing innovative cancer treatments.

Collaborations

Kienzle has collaborated with notable professionals in his field, including Anthony Gerard Doyle and Adam Clarke. These collaborations have further enhanced his research and development efforts in cancer therapies.

Conclusion

Norbert A Kienzle is a distinguished inventor whose work in cancer treatment is making a significant impact. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…